#piii hashtag - Bluesky

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call P3 Health Partners (NASDAQ: PIII) will release fourth quarter and full year 2025 financial results on March 26, 2026.Management will host a conference call at 1:30pm PT / 4:30pm ET on March 26, 2026, available by phone and live webcast at ir.p3hp.org. An archived recording will remain on the investor site for 90 days.

3 weeks ago

#PIII P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

P3 Health Partners (NASDAQ: PIII) launches JV MSO with Commonwealth ACO to grow value-based primary care footprint P3 and Commonwealth Primary Care ACO create a joint venture MSO, expanding P3’s value-based care platform and footprint, including entry into Maricopa County, AZ.

4 months ago

#PIII P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

www.stocktitan.net/news/PIII/p3-expands-foo...

0 0 0 0

P3 Health Partners Announces Third Quarter 2025 Results With the progress underway, we’ re confident in our ability to execute on the $120 to $170 million in EBITDA expansion opportunities identified, positioning us for sustainable profitability in 2026 and beyond.”. On a per-member basis, funding improved 6% from the prior year when adjusted for prior-period items. Medical margin for the quarter was $4.4 million, or...

4 months ago

#PIII P3 Health Partners Announces Third Quarter 2025 Results

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call P3 Health Partners (NASDAQ: PIII) will release third quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. Management will discuss results on a conference call at 5:00 AM PT / 8:00 AM ET the same day. The call is toll-free at 1-833-316-0546 (US) or 1-412-317-0692 (international), and will be webcast live from the company's Investor page at ir.p3hp.org.The press release will be posted on the Investor page in advance of the call. An archived recording of the webcast will be available on the Investor page for 90 days after the conference call.

5 months ago

#PIII P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

68,000 Medicare Members Impacted: Catalyst Solutions Launches Major Healthcare Implementation in 4 States Catalyst Solutions implements Professional Health Partners Services across AZ, OR, NV, and CA, supporting 11 health plans and 68,000 Medicare members. 60-day implementation completed in May 2025.

7 months ago

#PIII Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

www.stocktitan.net/news/PIII/catalyst-solut...

0 0 0 0

Richie’s Computer Stuff

@richiegolds.bsky.social

7 months ago

A screenshot of the MadOnion.com System Info window shows system specs for a Compaq PC running Windows 2000. The CPU is an Intel Pentium III at 797 MHz (800 MHz), with an NVIDIA GeForce FX 5500, 512MB of RAM, and motherboard model 0688h by Compaq. The tool version is 2.2.

A screenshot of the PCMark2002 Free results screen shows a benchmark with an Intel Pentium III at 800MHz. The scores are: CPU – 2168, Memory – 1481, and HDD – 996.

A second MadOnion.com System Info window shows the upgraded specs. The CPU is now an Intel Pentium III at 997 MHz (1 GHz), still paired with the GeForce FX 5500 and 512MB RAM. Free physical memory is listed as 386.52 MB. Motherboard info remains unchanged.

Another PCMark2002 Free results screen, now reflecting the upgraded CPU. The scores are improved: CPU – 2626, Memory – 1558, and HDD – 1000, indicating better performance from the 1GHz Pentium III.

That #compaqdeskproen #compaqdeskpro I showed? Got a CPU upgrade! Going from an 800MHz #pentium3 #p3 #pentiumiii to a 1GHz version got a 452 point (21%) increase in PCMark 2002! #compaq #pentium #piii #vintagepc #retropc #oldpc #oldcomputer #retrocomputer #windows2000 #2000snostalgia #coppermine

0 0 0 0

P3 Health Partners Announces Second Quarter 2025 Results P3 Health Partners (NASDAQ: PIII) reported Q2 2025 financial results, demonstrating resilience in its core business despite industry challenges. The company achieved flat medical cost trends and recorded total revenue of $355.8 million, down 6% year-over-year. Average at-risk membership decreased 9% to 115,000 members due to network rationalization.The company's medical margin was $30.6 million ($89 PMPM), while adjusted EBITDA showed a loss of $17.1 million ($50 PMPM). Notably, P3 has identified $120-$170 million in additional EBITDA opportunities for 2026. The company revised its FY2025 guidance, projecting total revenues between $1.35-$1.5 billion and adjusted EBITDA loss between $69-39 million.

7 months ago

#PIII P3 Health Partners Announces Second Quarter 2025 Results

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

Healthcare Provider P3 Health Partners Sets Q2 2025 Earnings Release Date - Conference Call Details Inside P3 Health to discuss Q2 2025 financial results on August 14. Join earnings call at 4:30 PM ET via toll-free dial-in or live webcast. Get access details.

8 months ago

#PIII P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

P3 Health Partners Announces First Quarter 2025 Results P3 Health Partners (NASDAQ: PIII) reported its Q1 2025 financial results, showing mixed performance. The company's revenue decreased 4% to $373.2 million compared to $388.5 million in Q1 2024. Average at-risk membership declined 8% to 115,900 members, while per-member funding PMPM increased 8% to $1,063. Medical margin fell to $17.2 million from $36.6 million, impacted by a $23 million negative adjustment from prior year claims. Adjusted EBITDA loss widened to $22.2 million from $19.8 million. Despite challenges, CEO Aric Coffman highlighted that three of four markets achieved breakeven or better in Q1, and the company's turnaround plan is ahead of schedule. P3 affirmed its 2025 guidance, projecting total revenues of $1.35-1.5 billion and at-risk members between 109,000-119,000.

10 months ago

#PIII P3 Health Partners Announces First Quarter 2025 Results

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call P3 Health Partners (NASDAQ: PIII) has announced it will release its first quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. The company will host a conference call with management to discuss the results at 4:30 PM ET/1:30 PM PT on the same day.Investors can join the conference call through the toll-free number 1-833-316-0546 (US) or internationally at 1-412-317-0692. A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. The webcast recording will remain accessible on the company's website for 90 days following the call.

10 months ago

#PIII P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

1 year ago

🚀 Exciting times for #PIII! Trading at $0.1776, it's showing mixed signals with potential support from the 10-day SMA. MACD hints at a bullish crossover, but watch out for market pressures. Consider a cautious long position: Entry $0.175, Targets $0.185/$0.195, Stop $0.165. 📈 #FeetrAI

1 0 0 0

P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results P3 Health Partners (NASDAQ: PIII) reported its Q4 and full-year 2024 financial results, showing mixed performance. Full-year revenue reached $1.50 billion, up 18% year-over-year, with capitated revenue increasing 18% to $1.48 billion.The company's at-risk membership grew 14% to 123,800 members. However, financial metrics showed significant challenges: Full-year net loss widened to $310.4 million from $186.4 million, while medical margin decreased 37% to $85.5 million. Q4 2024 results included total revenue of $370.7 million (up 7%) but showed a gross profit loss of $39.5 million.CEO Aric Coffman highlighted the company's fundamentally strong business model and identified $130M+ in programmatic opportunities to improve financial sustainability.

1 year ago

#PIII P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

1 year ago

🚀 Exciting times for #PIII! Trading at $0.176, it's showing mixed signals with a slight bullish divergence on the MACD. 📈 Consider a short-term long position with an entry at $0.175, targeting $0.185 & $0.195. Caution: low volume & market volatility ahead! #FeetrAI

0 0 0 0

1 year ago

🚨 FeetrAI Alert: #PIII is in the spotlight! Trading at $0.1755, it's showing mixed signals with a short-term bearish trend. 📉 Consider a short position with targets at $0.1700 & $0.1650. Stay sharp for news that could shake things up! 📊 #StockMarket #FeetrAI

0 0 0 0

1 year ago

🚨 FeetrAI Alert: #PIII is in the spotlight! Trading at $0.1761, it's showing mixed signals. With a potential bearish trend and low volume, a short position could be strategic. Enter at $0.175, target $0.165/$0.155, stop loss at $0.185. Stay sharp! 📉 #StockMarket #FeetrAI

0 0 0 0

1 year ago

🚀 Exciting times for #PIII! Trading at $0.1834, it's showing bullish vibes with a 10-day SMA of $0.1739 and an 8-day EMA of $0.1785. RSI hints at buying pressure, but watch out for volatility due to low volume. Consider a cautious long position! 📈 #FeetrAI #StockMarket

0 0 0 0

1 year ago

🚀 Exciting times for #PIII! Trading at $0.19, it's showing bullish momentum with a 10-day SMA of $0.1737 and a 20-day EMA of $0.1815. MACD is positive, but watch out for low volume and RSI nearing overbought. Target: $0.21/$0.23, Stop: $0.17. Stay alert! 📈 #FeetrAI

0 0 0 0

1 year ago

Bearish vibes for #PIII! 📉 Trading at $0.1715, it's below key moving averages with RSI showing weak buying pressure. MACD hints at a downtrend. Consider a SHORT position with targets at $0.165 & $0.160. Stay alert for earnings surprises! #FeetrAI #StockMarket

1 0 0 0

1 year ago

🚨 FeetrAI Alert: #PIII is in the spotlight! Trading at $0.1715, it's showing bearish vibes with potential for a minor rebound. Consider a SHORT at $0.172, targeting $0.165 & $0.160. Stay sharp with earnings on the horizon and delisting buzz! 📉 #StockMarket #FeetrAI

0 0 0 0

1 year ago

Bearish vibes for #PIII! Trading at $0.1717, it's below key moving averages with weak momentum. Consider a short at $0.172, targeting $0.165 & $0.160. Set stop loss at $0.175. Low volume hints limited downside risk, but stay alert for market shifts! #FeetrAI #StockAnalysis

0 0 0 0

1 year ago

🚨 Bearish Alert on #PIII! Trading at $0.1648, P3 Health Partners shows negative momentum with RSI nearing oversold. Below key SMAs, low volume, and no catalysts suggest a short position could be wise. Target: $0.160/$0.155, Stop: $0.170. Stay sharp! 📉 #FeetrAI

0 0 0 0

P3 Health Partners Eyes Profitability: Unveils Ambitious $1.5B Revenue Target for 2025 Healthcare provider targets 2025 profitability with $1.35-1.5B revenue forecast and up to $5M EBITDA. New $30M financing deal in discussion to fuel growth.

1 year ago

#PIII P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction

www.stocktitan.net/news/PIII/p3-health-part...

0 0 0 0

1 year ago

#PIII P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

www.stocktitan.net/news/PIII/p3-health-part...

2 0 0 0